Microwave ablation of malignant hepatic tumours: intraperitoneal fluid instillation prevents collateral damage and allows more aggressive case selection.

Microwave ablation of malignant hepatic tumours: intraperitoneal fluid instillation prevents collateral damage and allows more aggressive case selection.
复制标题

DOI:
10.3109/02656736.2014.936050
复制
发表时间:
2014-08
期刊:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
影响因子:
--
通讯作者:
Lee F
Lee F
中科院分区:
其他
文献类型:
--
作者:
Kitchin D;Lubner M;Ziemlewicz T;Hinshaw JL;Alexander M;Brace CL;Lee F

文献摘要

参考文献

被引文献

相似文献

Theaim of this peper was to retrospectively review our experience utilising protective fluid instillation techniques during percutaneous microwave ablation of liver tumours to determine if fluid instillation prevents non-target injuries and allows a more aggressive case selection. This institute review board-approved, US Health Insurance Portability and Accountability Act-compliant, retrospective study reviewed percutaneous microwave ablation of 151 malignant hepatic tumours in 87 patients, comparing cases in which protective fluid instillation was performed with those where no fluid was utilised. In cases utilising hydrodisplacement for bowel protection, a consensus panel evaluated eligibility for potential ablation without hydrodisplacement. Patient age, tumour size, local tumour progression rate, length of follow-up, complications, displacement distance/artificial ascites thickness, and treatment power/time were compared. Fluid administration was utilised during treatment in 29/151 of cases: 10/29 for protection of bowel (8/10 cases not possible without fluid displacement), and 19/29 for body wall/diaphragm protection. Local tumour progression was higher when hydrodisplacement was used to protect bowel tissue; this may be due to lower applied power due to operator caution. Local tumour progression was not increased for artificial ascites. There was no difference in complications between the fluid group and controls. Intraperitoneal fluid administration is a safe and effective method of protecting non-target structures during percutaneous hepatic microwave ablation. While hydrodisplacement for bowel protection allows more aggressive case selection, these cases were associated with higher rates of local tumour progression.
DOI: 10.2214/ajr.183.1.1830197
发表时间: 2004-07-01
影响因子: 5
作者:
Raman, SS;Aziz, D;Lu, D
通讯作者: Lu, D
DOI: 10.2214/ajr.05.0140
发表时间: 2006-05-01
影响因子: 5
作者:
Hinshaw, JL;Laeseke, PF;Lee, FT
通讯作者: Lee, FT
DOI: 10.1007/s00535-003-1181-0
发表时间: 2003-10-01
影响因子: 6.3
作者:
Hori, T;Nagata, K;Tsubouchi, H
通讯作者: Tsubouchi, H
DOI: 10.2214/ajr.172.1.9888741
发表时间: 1999-01-01
影响因子: 5
作者:
Ohmoto, K;Tsuzuki, M;Yamamoto, S
通讯作者: Yamamoto, S
DOI: 10.1080/13651820701646222
发表时间: 2007-01-01
期刊: HPB : the official journal of the International Hepato Pancreato Biliary Association
影响因子: --
作者:
Awad, Michael M;Devgan, Lara;Choti, Michael A
通讯作者: Choti, Michael A